タイトルまたは説明

Buparvaquone Injection 5%

Composition:

Each ml contains:

Buparvaquone..................................................*0mg

Excipients ad.......................................................1ml

Description:

Buparvaquone is a second-generation hydroxynaphtaquinone with novel features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis.

Indications:

For treatment of tick-transmitted theileriosis caused by the intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against both the schizont and piroplasm stages of Theileria spp. and may be used during the incubation period of the disease, or when clinical signs are apparent.

Contra-indications:

Due to the inhibiting effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.

Side Effects:

Localised, painless, oedematous swelling may occasionally be seen at the injection site.

Administration andDosage: 

For intramuscular injection.

The general dosage is 1 ml per *0 kg body weight.

In severe cases the treatment may be repeated within *8 - *2 hours. Do not administer more than *0 ml per injection site. Successive injections should be administered at different sites.

Withdrawal Times:

For meat: *2 days.

For milk: 2 days.

Storage:

Storebelow *5ºC,in a cool and dry place, and protect from light.

For Veterinary Use Only

Keep out of reach of children